Aeolus Announces Second Quarter Fiscal Year 2016 Financial Results and Investor Update Call
16 mai 2016 08h00 HE
|
Aeolus Pharmaceuticals
MISSION VIEJO, CA--(Marketwired - May 16, 2016) -
Aeolus Pharmaceuticals, Inc.
(OTCQB: AOLS), a biotechnology company developing compounds to protect against fibrosis, inflammation,...
European Patent Issued and Patent Allowed in Japan for Aeolus' Parkinson's Disease Compound AEOL 11114
18 avr. 2016 08h00 HE
|
Aeolus Pharmaceuticals
MISSION VIEJO, CA --(Marketwired - April 18, 2016) - Aeolus Pharmaceuticals (OTCQB: AOLS)
AEOL 11114 Is Subject of Michael J Fox Foundation Research Grant Program
...
Aeolus Announces Removal of FDA Clinical Hold on AEOL 10150; Initiation of Phase 1 Study in Healthy Volunteers Planned for 2nd Quarter 2016
22 févr. 2016 08h00 HE
|
Aeolus Pharmaceuticals
MISSION VIEJO, CA--(Marketwired - February 22, 2016) - Aeolus Pharmaceuticals, Inc.(OTCQB: AOLS), a biotechnology company developing compounds to protect against fibrosis, inflammation, nerve...
Aeolus Announces First Quarter Fiscal Year 2016 Financial Results
16 févr. 2016 17h08 HE
|
Aeolus Pharmaceuticals
MISSION VIEJO, CA--(Marketwired - February 16, 2016) -
Aeolus Pharmaceuticals, Inc.
(OTCQB: AOLS), a biotechnology company developing compounds to protect against fibrosis, inflammation,...
Aeolus Announces Fiscal Year 2015 Financial Results
18 déc. 2015 17h09 HE
|
Aeolus Pharmaceuticals
MISSION VIEJO, CA--(Marketwired - December 18, 2015) -
Aeolus Pharmaceuticals, Inc.
(OTCQB: AOLS), a biotechnology company developing compounds to protect against radiological and...
Aeolus Announces $6.75 Million Private Placement Financing
15 déc. 2015 15h22 HE
|
Aeolus Pharmaceuticals
MISSION VIEJO, CA--(Marketwired - December 15, 2015) -
Aeolus Pharmaceuticals, Inc.
(OTCQB: AOLS), a biotechnology company developing compounds to protect against fibrosis, inflammation,...
Aeolus Announces $6.75 Million Private Placement Financing
14 déc. 2015 07h00 HE
|
Aeolus Pharmaceuticals
MISSION VIEJO, CA--(Marketwired - December 14, 2015) -
Aeolus Pharmaceuticals, Inc.
(OTCQB: AOLS), a biotechnology company developing compounds to protect against fibrosis, inflammation,...
Aeolus Announces Formation of Pulmonary Fibrosis Clinical Advisory Board
04 nov. 2015 08h30 HE
|
Aeolus Pharmaceuticals
MISSION VIEJO, CA--(Marketwired - November 04, 2015) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS), a biotechnology company developing compounds to protect against fibrosis, inflammation, nerve damage...
Aeolus Receives Notice of Patent Allowance for New Compound That Demonstrated Efficacy in Michael J. Fox Foundation Research Grant Program
02 nov. 2015 08h30 HE
|
Aeolus Pharmaceuticals
MISSION VIEJO, CA--(Marketwired - November 02, 2015) - PRE-CLINICAL WORK UNDERWAY WITH IND FILING FOR PARKINSON'S DISEASE TARGETED IN 2017EFFICACY DEMONSTRATED IN TWO PARKINSON'S DISEASE MODELS...
Aeolus Announces Publication of Study Showing AEOL 10150 Improves Memory and Protects Brain Damage in an Animal Model of Epilepsy
18 août 2015 08h00 HE
|
Aeolus Pharmaceuticals
MISSION VIEJO, CA--(Marketwired - August 18, 2015) - FINDINGS REPORTED BY DR. MANISHA PATELOF THE UNIVERSITY OF COLORADO ANSCHUTZ MEDICAL CAMPUS, DEPARTMENT OF PHARMACEUTICAL SCIENCES AND PUBLISHED...